Physician profile
Matthew Mast
NPI 1760593735
$4,171.95
in general payments reported to CMS, 2019-2025
22 companies · $1,368 in 2025
The $1,368 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $719 · 2021: $765 · 2022: $431 · 2023: $423 · 2024: $271 · 2025: $1,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,986 · Entertainment: $59.50 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,985.57 |
| Entertainment | $59.50 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $899.84 | 2020-2025 | Clariti Contact Lens, Misight Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $884.48 | 2020-2025 | Total30, Precision 1, Precision7 |
| Johnson & Johnson Vision Care, INC. | $602.60 | 2019-2025 | Acuvue |
| Eyevance Pharmaceuticals LLC | $330.20 | 2021 | |
| Novartis Pharmaceuticals Corporation | $244.26 | 2019-2023 | |
| Abb Con-Cise Optical Group LLC | $155.09 | 2025 | Contact Lens, Spectacle Lenses |
| Rxsight INC | $137.56 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $124.59 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $122.64 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $117.38 | 2025 | Tecnis Iol |
| Ivantis, INC | $88.24 | 2020 | |
| Bausch & Lomb Americas INC. | $84.01 | 2022-2024 | Miebo, Xiidra |
| Allergan, INC. | $70.56 | 2020-2022 | |
| Harrow Eye, LLC | $70.35 | 2025 | Vevye |
| Oyster Point Pharma, INC. | $61.28 | 2022-2023 | Tyrvaya |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $59.50 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.25 | 2019 | |
| Menicon America INC | $22.14 | 2019 | |
| Shire North American Group INC | $16.56 | 2019 | |
| Sight Sciences, INC. | $15.92 | 2022 | |
| Kala Pharmaceuticals, INC. | $14.27 | 2021 | |
| Maculogix, INC. | $14.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.